Logo image of CTOS

CUSTOM TRUCK ONE SOURCE INC (CTOS) Stock Fundamental Analysis

NYSE:CTOS - New York Stock Exchange, Inc. - US23204X1037 - Common Stock - Currency: USD

5.14  +0.14 (+2.8%)

After market: 5.14 0 (0%)

Fundamental Rating

2

Overall CTOS gets a fundamental rating of 2 out of 10. We evaluated CTOS against 49 industry peers in the Trading Companies & Distributors industry. CTOS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CTOS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CTOS had negative earnings in the past year.
In the past year CTOS had a positive cash flow from operations.
In multiple years CTOS reported negative net income over the last 5 years.
CTOS had a positive operating cash flow in 4 of the past 5 years.
CTOS Yearly Net Income VS EBIT VS OCF VS FCFCTOS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.91%, CTOS is doing worse than 75.51% of the companies in the same industry.
The Return On Equity of CTOS (-3.95%) is worse than 75.51% of its industry peers.
CTOS's Return On Invested Capital of 3.94% is on the low side compared to the rest of the industry. CTOS is outperformed by 65.31% of its industry peers.
CTOS had an Average Return On Invested Capital over the past 3 years of 5.22%. This is below the industry average of 9.84%.
Industry RankSector Rank
ROA -0.91%
ROE -3.95%
ROIC 3.94%
ROA(3y)0.67%
ROA(5y)-1.5%
ROE(3y)2.19%
ROE(5y)N/A
ROIC(3y)5.22%
ROIC(5y)3.81%
CTOS Yearly ROA, ROE, ROICCTOS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

CTOS has a Operating Margin (6.27%) which is comparable to the rest of the industry.
CTOS's Operating Margin has declined in the last couple of years.
CTOS has a worse Gross Margin (21.24%) than 75.51% of its industry peers.
CTOS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.27%
PM (TTM) N/A
GM 21.24%
OM growth 3Y99.85%
OM growth 5Y-16.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.37%
GM growth 5Y-7.39%
CTOS Yearly Profit, Operating, Gross MarginsCTOS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CTOS is destroying value.
The number of shares outstanding for CTOS has been reduced compared to 1 year ago.
The number of shares outstanding for CTOS has been increased compared to 5 years ago.
The debt/assets ratio for CTOS has been reduced compared to a year ago.
CTOS Yearly Shares OutstandingCTOS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CTOS Yearly Total Debt VS Total AssetsCTOS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

CTOS has an Altman-Z score of 0.74. This is a bad value and indicates that CTOS is not financially healthy and even has some risk of bankruptcy.
CTOS has a Altman-Z score of 0.74. This is amonst the worse of the industry: CTOS underperforms 91.84% of its industry peers.
CTOS has a Debt/Equity ratio of 1.96. This is a high value indicating a heavy dependency on external financing.
CTOS's Debt to Equity ratio of 1.96 is on the low side compared to the rest of the industry. CTOS is outperformed by 77.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Altman-Z 0.74
ROIC/WACC0.33
WACC11.91%
CTOS Yearly LT Debt VS Equity VS FCFCTOS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

CTOS has a Current Ratio of 1.29. This is a normal value and indicates that CTOS is financially healthy and should not expect problems in meeting its short term obligations.
CTOS has a worse Current ratio (1.29) than 81.63% of its industry peers.
CTOS has a Quick Ratio of 1.29. This is a bad value and indicates that CTOS is not financially healthy enough and could expect problems in meeting its short term obligations.
CTOS has a Quick ratio of 0.24. This is amonst the worse of the industry: CTOS underperforms 91.84% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.24
CTOS Yearly Current Assets VS Current LiabilitesCTOS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for CTOS have decreased strongly by -330.00% in the last year.
The Revenue has decreased by -0.61% in the past year.
The Revenue has been growing by 46.84% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-330%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y15.58%
Revenue growth 5Y46.84%
Sales Q2Q%2.66%

3.2 Future

Based on estimates for the next years, CTOS will show a very strong growth in Earnings Per Share. The EPS will grow by 35.46% on average per year.
Based on estimates for the next years, CTOS will show a small growth in Revenue. The Revenue will grow by 6.22% on average per year.
EPS Next Y77.66%
EPS Next 2Y54.86%
EPS Next 3Y35.46%
EPS Next 5YN/A
Revenue Next Year7.58%
Revenue Next 2Y6.63%
Revenue Next 3Y6.22%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTOS Yearly Revenue VS EstimatesCTOS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CTOS Yearly EPS VS EstimatesCTOS Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CTOS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
CTOS is valuated quite expensively with a Price/Forward Earnings ratio of 61.45.
77.55% of the companies in the same industry are cheaper than CTOS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.90. CTOS is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 61.45
CTOS Price Earnings VS Forward Price EarningsCTOS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

CTOS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTOS is cheaper than 85.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.76
CTOS Per share dataCTOS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

CTOS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTOS's earnings are expected to grow with 35.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y54.86%
EPS Next 3Y35.46%

More info and screens

0

5. Dividend

5.1 Amount

CTOS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUSTOM TRUCK ONE SOURCE INC

NYSE:CTOS (7/3/2025, 7:14:30 PM)

After market: 5.14 0 (0%)

5.14

+0.14 (+2.8%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners27.32%
Inst Owner Change-3.4%
Ins Owners2.9%
Ins Owner Change12.15%
Market Cap1.16B
Analysts78.33
Price Target5.92 (15.18%)
Short Float %9.64%
Short Ratio9.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-40.85%
Min EPS beat(2)-50.98%
Max EPS beat(2)-30.72%
EPS beat(4)0
Avg EPS beat(4)-194.38%
Min EPS beat(4)-553.59%
Max EPS beat(4)-30.72%
EPS beat(8)1
Avg EPS beat(8)-124.45%
EPS beat(12)4
Avg EPS beat(12)22.75%
EPS beat(16)5
Avg EPS beat(16)-148.22%
Revenue beat(2)0
Avg Revenue beat(2)-5.66%
Min Revenue beat(2)-6.04%
Max Revenue beat(2)-5.28%
Revenue beat(4)0
Avg Revenue beat(4)-5.79%
Min Revenue beat(4)-9.62%
Max Revenue beat(4)-2.21%
Revenue beat(8)3
Avg Revenue beat(8)-1.04%
Revenue beat(12)5
Avg Revenue beat(12)-0.13%
Revenue beat(16)7
Avg Revenue beat(16)0.42%
PT rev (1m)-1.69%
PT rev (3m)-5.95%
EPS NQ rev (1m)-13.64%
EPS NQ rev (3m)-66.67%
EPS NY rev (1m)28.13%
EPS NY rev (3m)-294.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 61.45
P/S 0.64
P/FCF N/A
P/OCF 6.06
P/B 1.43
P/tB N/A
EV/EBITDA 7.76
EPS(TTM)-0.23
EYN/A
EPS(NY)0.08
Fwd EY1.63%
FCF(TTM)-1.07
FCFYN/A
OCF(TTM)0.85
OCFY16.49%
SpS8.01
BVpS3.59
TBVpS-0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.91%
ROE -3.95%
ROCE 4.51%
ROIC 3.94%
ROICexc 3.95%
ROICexgc 6.35%
OM 6.27%
PM (TTM) N/A
GM 21.24%
FCFM N/A
ROA(3y)0.67%
ROA(5y)-1.5%
ROE(3y)2.19%
ROE(5y)N/A
ROIC(3y)5.22%
ROIC(5y)3.81%
ROICexc(3y)5.24%
ROICexc(5y)3.82%
ROICexgc(3y)9%
ROICexgc(5y)6.62%
ROCE(3y)5.98%
ROCE(5y)4.36%
ROICexcg growth 3Y112.25%
ROICexcg growth 5Y-5.47%
ROICexc growth 3Y121.67%
ROICexc growth 5Y-4.41%
OM growth 3Y99.85%
OM growth 5Y-16.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.37%
GM growth 5Y-7.39%
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 1.96
Debt/FCF N/A
Debt/EBITDA 4.48
Cap/Depr 179.76%
Cap/Sales 23.97%
Interest Coverage 0.73
Cash Conversion 54.02%
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.24
Altman-Z 0.74
F-Score3
WACC11.91%
ROIC/WACC0.33
Cap/Depr(3y)162.56%
Cap/Depr(5y)132.08%
Cap/Sales(3y)21.1%
Cap/Sales(5y)20.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-330%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y77.66%
EPS Next 2Y54.86%
EPS Next 3Y35.46%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y15.58%
Revenue growth 5Y46.84%
Sales Q2Q%2.66%
Revenue Next Year7.58%
Revenue Next 2Y6.63%
Revenue Next 3Y6.22%
Revenue Next 5YN/A
EBIT growth 1Y-31.13%
EBIT growth 3Y130.99%
EBIT growth 5Y22.21%
EBIT Next Year216.46%
EBIT Next 3Y60.78%
EBIT Next 5YN/A
FCF growth 1Y25.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.9%
OCF growth 3Y-4.24%
OCF growth 5Y45.35%